Now available: Multi-omics data to boost your research! One partner, one sample, two sets of data. You can now order from Nightingale Health both metabolomic and proteomic analysis from the same samples.

Are you coming to the EASD Annual Meeting 2025 in Vienna next week? Come meet our team at booth D3.03 and hear more about Nightingale Health’s affordable metabolomics and scalable remote blood collection. You can now order both metabolomic and proteomic analysis from the same samples.

Our webinar “Multi-omic insights into human disease” by @jeffbarrett.eu is next week! Remember to sign up and join us on 4 September at 3 p.m. CEST. Sign up: www.lyyti.fi/reg/multiomi...

Are you coming to ESC Congress 2025 in Madrid? Come meet our team at booth A545 and hear more about Nightingale Health’s affordable metabolomics and scalable remote blood collection. You can now order both metabolomic and proteomic analysis from the same samples. @escardio.bsky.social

Welcome to our webinar “Multi-omic insights into human disease” by @jeffbarrett.eu on 4 September at 3 p.m. CEST! Join us for an exploration of how integrating proteomics and metabolomics can deepen our understanding of human health and disease. Learn more and sign up: www.lyyti.fi/reg/multiomi...

Now available: Multi-omics data to boost your research! You can now order from us both metabolomic and proteomic analysis from the same samples. To learn more, join our webinar 'Multi-omic insights into human disease' by @jeffbarrett.eu on September 4. www.lyyti.fi/reg/multiomi...

📣 Our webinar “Measuring the effects of aging with metabolomic profiling” by @lukejostins.bsky.social is tomorrow! Remember to sign up and join us tomorrow at 3 p.m. CEST. Sign up: www.lyyti.fi/reg/aging_we...

Are you coming to Wellcome Connecting Science Learning and Training's event: Multiomics in Metabolic Disease on June 4-6? In the event, our Chief Scientific Officer, Jeffrey Barrett, will have a poster presentation. You can also meet our team and hear more about Nightingale Health!

Welcome to our webinar “Measuring the effects of aging with metabolomic profiling” on 3 June at 3 p.m. CEST by our Principal Scientist Dr. @lukejostins.bsky.social. Learn more and sign up: www.lyyti.fi/reg/aging_we...

Are you coming to @eshg.bsky.social Conference 2025 on May 24-27? Our Principal Scientist, @lukejostins.bsky.social, will have a poster presentation, and you can also meet our team at booth 134 during the event.

New in our Research blog: From Studies of Diabetes Patients to General Population Cohorts "Urine metabolomics offers molecular links between exposures and disease risk, for example as readouts of diet and gut microbiome." Read the blog post: research.nightingalehealth.com/blog/urine-m...

Are you coming to joint Congress of ESPE and ESE 2025 in Copenhagen on May 10-13? Come meet our team at booth E56 and hear more about Nightingale Health’s affordable metabolomics and scalable remote blood collection.

Are you coming to European Atherosclerosis Society Congress 2025 in Glasgow on May 4-7? Come meet our team at booth 20 and hear more about Nightingale Health’s affordable metabolomics and scalable remote blood collection. Book a meeting to discuss more: [email protected]

A new podcast shows how AI sees Nightingale Health 🎧 The Nordic Venture Show is an AI-enhanced short-format podcast exploring Nordic startups, innovation, and venture capital. Listen how AI sums up Nightingale Health in just 12 minutes: open.spotify.com/episode/2kp6...

Are you attending the DS4HB Workshop on April 7-9? Our Senior Data Scientist, Mattia Cordioli, and Director of Sales, Jussi Sievälä, will be at the event and would love to connect with you and tell how Nightingale Health can boost your research. Book a meeting: [email protected]

💡 Maternal research highlight: A multi-cohort study examines how pregnancy and perinatal complications impact offspring metabolic traits over time Access the full publication: bmcmedicine.biomedcentral.com/articles/10....

The CARICE Conference at King's College London brought scientists together to discuss transformative and impactful research to improve ageing resilience. Thank you to Professor Claire Steves and @kingscollegelondon.bsky.social for an inspiring conference in the forefront of aging research!

Time to celebrate yet another milestone 🔔 🎉 Nightingale Health has officially transferred from First North Growth List to Main Market of Nasdaq Helsinki and the trading in the Shares commenced on the Main Market of Nasdaq Helsinki today on 19 March 2025.

NMR-based metabolomic profiling improves the prediction of gestational diabetes A recent study compared the current method of predicting gestational diabetes to the combination of blood metabolomic biomarkers and maternal clinical risk factors. Learn more: www.ajog.org/article/S000...

According to the IDF, half a million diabetes-related deaths were preventable in Europe in 2021. Research using Nightingale Health’s metabolomic blood profiling shows that a single blood test can identify individuals at 6-10x higher risk of type 2 diabetes – years before diagnosis. Read more:

Our webinar “Metabolomic Profiling: Applications to Maternal Health Research” by Peter Würtz is next week! Remember to sign up and join us on 26 February at 3 p.m. CET. Learn more and sign up: www.lyyti.fi/reg/maternal...

💡 Research highlight: Early metabolic markers of gestational diabetes in obese pregnant women A study published in Diabetologia investigated metabolic differences between obese pregnant women who developed gestational diabetes and those who did not. Learn more: link.springer.com/article/10.1...

Welcome to our webinar "Metabolomic Profiling: Applications to Maternal Health Research" on Feb 26! Our Founder & Scientific Advisor, Peter Würtz, will cover the latest science on maternal and inter-generational health using NMR metabolomics. Learn more and sign up: www.lyyti.fi/reg/maternal...

Are you coming to The Festival of Genomics & Biodata in London on January 29-30? Come meet our team at booth 27 and hear more about Nightingale Health’s affordable metabolomics and scalable remote blood collection. See you at the event!

💡 Research highlight: A UK birth cohort study explored whether integrating nuclear magnetic resonance -based metabolomics with traditional risk factors could improve the prediction of pregnancy-related complications. Learn more: bmcmedicine.biomedcentral.com/articles/10....

Greetings from Singapore! 🇸🇬 A few weeks ago, our CEO & Founder, Teemu Suna, participated in a panel discussion called ‘Translating Research Data into Innovations and Global Welfare’ at the Embassy of Finland in Singapore. Thank you for having us Embassy of Finland and Ambassador Juha Markkanen!

Are you coming to Wellcome Connecting Science Learning and Training's event: 👩‍🔬 Women's Health: Genes, Data and Advancing Approaches on January 27-29? Our Founder & Scientific Advisor Peter Würtz will have a poster presentation. You can also meet our team and hear more about Nightingale Health.

Are you attending the UK Biobank Scientific Conference on December 10? Our Founder & Scientific Advisor, Peter Würtz, and Head of Global Medical Research Business, Helena Sundberg, will be at the event and would love to connect with you! Book a meeting to talk more: [email protected]

Today, we had the the opening ceremony of our Singapore laboratory. The laboratory is now ready to serve healthcare and medical research customers in the Southeast Asia region. Thank you everyone who joined the event to celebrate with us! 💜

Welcome to our webinar on 4 Dec. at 11 a.m. EST! In the webinar, our Data Scientist, Kirsten Schut, will highlight how metabolomic profiles not only predict diabetes onset but also reveal insights into the progression of diabetes-related complications and mortality. Sign up: ngh.site/webinar-dece...

💬 “The story of Nightingale Health started a decade ago. It all started from a vision. A vision to enable a better healthcare system. A better healthcare system for everyone." 💡 Read more about our mission, link in bio!